Utah Medical Cannabis 2022 Update - Initial Training

Thursday, September 1, 2022, 6:30 AM - Tuesday, September 30, 2025, 10:30 AM


AMA PRA Category 1 Credits™ (4.00 hours), Non-Physician Participation AMA PRA Category 1 Credits™ (4.00 hours)

Release Date: September 1, 2022 / Expiration Date: September 30, 2025

This activity is intended for prescribers, legal counsel and other allied health professionals who have an interest in the Utah Medical Cannabis Law and how it will impact them. This activity will fulfill the education requirement to be registered in the State of Utah as a qualified medical provider.

Instructions on how to complete course:

• Go to the "Resources & Tests" tab
• Complete the pre-tests to each section
• Watch the video recordings and read attached documentation
• Complete the post-tests associated with the recorded videos with a score of 75% or better  (You will have 2 attempts to pass each test)
• Once all post-tests have been passed, fill out the evaluation found in your "My CE" area under the "Evaluations & Certificates" area.
• Credit should then be automatically awarded on your transcript

Disclosure: None of the speaker(s), planner(s), or anyone in control of this educational content have any relevant financial relationships to disclosure.

Acknowledgment of Commercial Support: No commercial support is being received for this activity.

System Requirements:

•  Operating Systems: Any operating system that supports modern web browsers that adhere to the WC III standards.
•  Browsers: For best performance and compatibility, we recommend using the latest version of Firefox or Chrome. The CloudCME® administration system will run in Internet Explorer, Safari and the iOS browser though performance and display of some items may vary.
• Cookies: Cookies must be enabled in your browser to allow the system to operate. Cookies are not used to store any personal information, but are used by the program for basic screen management operations.
• JavaScript: JavaScript must be enabled in your browser to allow the system to operate. The only time JavaScript would not be enabled is if you work in an environment where the IT department has disabled JavaScript
• Security: Setting the browser security to Medium High or High may disable certain operations in CloudCME®. Browser security should be set to the default, standard settings.
• Screen Resolution: A minimum resolution of 1024x768 can be used, but due to the large amount of data on many screens the highest resolution available on your system will provide more usable space and make using CloudCME® more efficient.

Confidentiality Policy: Confidentiality Policy.pdf
Please contact [email protected] or 801-507-8470 with questions.

1. Summarize and describe key details of the Utah Medical Cannabis Act
2. Compare available formulation allowed in the State of Utah and differentiate between tetrahydrocannabidiol (THC) and cannabidiol (CBD)
3. Review available literature for cannabis use in various qualifying conditions included in the Utah Medical Cannabis Act
4. Describe the risks and benefits of medical cannabis use in special populations
5. Discuss available medical cannabis resources for providers and patients

Physician and APP registration fee - $150

Intermountain Healthcare is accredited by the Accreditation Council for Continuing Medical Education (ACCME)to provide continuing medical education for physicians. 

Intermountain Healthcare designates this enduring material for 4.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Mitigation of Relevant Financial Relationships

Intermountain Healthcare - Interprofessional Continuing Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.